Yasushi Goto

1. HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
   2023/09/10 by Helena A. Yu, Yasushi Goto, Hidetoshi Hayashi +35 · 1 citation
   Medicine · #HER2/EGFR in Cancer Research #Lung Cancer Research Studies #Lung Cancer Treatments and Mutations